Oxidative stress effects the rate of pregnancy
ROS have a negative impact on number and quality of oocytes and embryos. ( in IVF too)
To combat the hazards of ROS on women health , to improve the quality of pregnancy and to decrease the rate of abortion
DORMI has the solution to all the problems related to your conception health .
DORMI is a suicidal terminal anti oxidant
Which generate metabolites that are also capable of action as antioxidant in “Scavenging Cascade Reaction”
Also it enhances the activity of endogenous antioxidant
Including glutathione peroxidase and superoxide dismutase.
DORMI is manufactured using pharmacological grade 1 US imported raw material and product complies with all GMP standards.
DORMI ( Melatonin ) has a neuro protective effect both in adult and fetal brain.
*Melatonin is an important regulator of the complex embryo fetal developmental processes, also it protects highly metabolic ROS producing organs in the development from the oxidative stress damage.
(CONCLUSION from refrence JOURNAL OF MEDICINE AND LIFE )
*Severe pre-eclampsia has been reported to be associated with low levels of melatonin.
( STUDY from UNIVERSITY OF ABERDEEN)
*Oxidative stress effects the quality of oocytes and embroys decreasing the fertilisation rate and the success of the infertility treatment.
( INFERTILITY TREATMENT segment from JOURNAL OF OVARIAN RESEARCH)
*Melatonin is an effective mitigator of mitochondrial DNA damage as a result of an increase in ET efficiency within mitochondria leading to prevention of formation of ROS , leading to its possible use in treatment of infertility and improvement of oocyte quality and maturity.
( EFFECTS OF MELATONIN ON OOCYTE QUALITY segment from JOURNAL OF OVARIAN RESEARCH)
*Infertility treatments are associated with significant levels of reactive oxygen species which have the potential to negatively effect the quality of oocyte and the embryos. Melatonin shows promise as an adjunctive therapy in the treatment of infertility.
Its unique anti oxidative characteristics and safety profile make it an ideal potential adjuvant therapy.
( CONCLUSION from JOURNAL OF OVARIAN SEARCH)
